JF
ZBIO

Jump Financial’s Zenas BioPharma ZBIO Stock Holding History

Jump Financial’s Portfolio ZBIO Stock Details ZBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.29M Sell
51,022
-8,979
-15% -$178K 0.01% 1066
2026
Q1 		$1.17M Buy
+60,001
New +$1.35M 0.02% 858

Other funds holding ZBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
RPSM
Royalty Pharma Sub-Manager New York $242M AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return

Jump Financial's ZBIO Position: Q2 2026 in Review

Jump Financial reduced its Zenas BioPharma (ZBIO) stake by 15% in Q2 2026, selling an estimated $178K and leaving 51,022 shares worth $1.29M. The position accounts for 0.01% of the portfolio, ranked #1066.

Jump Financial first reported a position in ZBIO in Q1 2026 and has held it in 2 quarters since. 144 funds tracked by Wall St. Rank hold ZBIO as of Q2 2026.

  • Jump Financial held 51,022 shares of Zenas BioPharma worth $1.29M as of Q2 2026.
  • Jump Financial sold 8,979 Zenas BioPharma shares in Q2 2026, an estimated $178K.
  • Zenas BioPharma made up 0.01% of Jump Financial's portfolio in Q2 2026, its #1066 holding.
  • Jump Financial first reported a position in Zenas BioPharma in Q1 2026 and has held it in 2 quarters since.
  • 144 funds tracked by Wall St. Rank held Zenas BioPharma as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.